Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ani Deshpande"'
Autor:
Peter D. Adams, Darren Finlay, Anne Louise Latif, Mhairi Copland, Helen Stewart, Ashley Newcombe, Neil Robertson, Brian Higgins, Sha Li, Kathryn Gilroy, Ani Deshpande, Karina Barbosa, Timothy Chevassut, Xu Huang, Karen Keeshan, Xue Lei
Publikováno v:
Cancer Research. 80:3426-3426
Acute Myeloid Leukemia (AML) is a typically-lethal molecularly heterogeneous disease, with few broad-spectrum therapeutic targets. Unusually, over 90% of AML patients retain wild type TP53, encoding pro-apoptotic tumor suppressor p53. However, wild-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::141950e8b137d2e9b25f653c6a5b3754
https://doi.org/10.1158/1538-7445.am2020-3426
https://doi.org/10.1158/1538-7445.am2020-3426
Autor:
Carl F. Ware, Louis Chesler, Robert J. Wechsler-Reya, Marco A. Marra, Xiao-Nan Li, Yoon Jae Cho, Hiromichi Suzuki, Patryk Skowron, Linda M. Bradley, Nina Thiessen, Megan M. Romero, Yussanne Ma, Ani Deshpande, Alexandra Garancher, Andrew J. Mungall, Michael J. Levy, Jacob J. Henderson, Meher Beigi Masihi, Sorana Morrissy, Florence Cavalli, Michael D. Taylor, Paula S. Norris, Florent Carrette, Richard A. Moore, Yisu Li, Vijay Ramaswamy, John R. Crawford, Alaide Morcavallo, Oren J. Becher, Lin Qi, Jessica M. Rusert, Svasti Haricharan, James M. Olson, Steven J.M. Jones, Hamza Farooq
Many immunotherapies act by enhancing the ability of T cells to kill tumor cells. But T cell killing depends on recognition of antigens presented by Class I MHC (MHC-I) on the tumor cell surface; if a tumor lacks MHC-I, it cannot be recognized by T c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ac01b827c43204f1c326673de4519a
https://europepmc.org/articles/PMC6477198/
https://europepmc.org/articles/PMC6477198/
Autor:
Sha Li, Anne-Louise Latif, Ashley Newcombe, Kathryn Gilrory, Neil Robertson, Darren Finlay, Xue Lei, Helen Stewart, Karina Barbosa, John Cole, Maria Terradas Terradas, Loveena Rishi, Lynn McGarry, Claire McKeeve, Claire Reid, William Clark, Joana Campos, Kristina Kirschner, Jonathan Lopez, Jun-Ichi Sakamaki, Jennifer Morton, Kevin Ryan, Stephen Tait, Sheela Abraham, Tessa Holyoake, Brian Higgins, Xu Huang, Mhairi Copland, Tim Chevassut, Ani Deshpande, Karen Keeshan, Peter Adams
Publikováno v:
Experimental Hematology. 88:S70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b3862009165d9bdb156e4fd5d23c563
https://doi.org/10.1016/j.exphem.2020.09.115
https://doi.org/10.1016/j.exphem.2020.09.115
Autor:
Robert Wechsler-Reya, Alexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, Meher Beigi Masihi, Jessica M. Rusert, Paula S. Norris, Florent Carrette, Megan M. Romero, Sorana A. Morrissy, Patryk Skowron, Florence M.G. Cavalli, Hamza Farooq, Vijay Ramaswamy, Steven J.M. Jones, Richard A. Moore, Andrew J. Mungall, Yussanne Ma, Nina Thiessen, Yisu Li, Alaide Morcavallo, Lin Qi, Jacob J. Henderson, John R. Crawford, Michael L. Levy, James M. Olson, Yoon-Jae Cho, Ani Deshpande, Xiao-Nan Li, Louis Chesler, Marco A. Marra, Oren J. Becher, Linda M. Bradley, Carl F. Ware, Michael D. Taylor
Publikováno v:
The Journal of Immunology. 202:194.41-194.41
Many immunotherapies act by enhancing T cell killing of tumor cells. CD8+ cytotoxic T cells recognize antigens presented by class I major histocompatibility complex (MHC-I) proteins on tumor cells. Here we show that medulloblastomas lacking the p53 t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35642c100a0d496ef95ff09d01819280
https://doi.org/10.4049/jimmunol.202.supp.194.41
https://doi.org/10.4049/jimmunol.202.supp.194.41
Publikováno v:
Molecular Oncology; Jan2024, Vol. 18 Issue 1, p233-237, 5p
Publikováno v:
Oncology Times; 2021 Supplement, Vol. 43, p16-16, 3/4p
Autor:
Wilkin, Richard, Clouston, Hamish, Coe, Peter, Duarte, Rui, Stott, Martyn, Pockney, Peter, Egoroff, Natasha, Mehta, Samir, Brown, James, Magill, Laura, Ives, Natalie, Fish, Rebecca, Glasbey, James, Duff, Sarah, Pinkney, Thomas, Johnstone, Elisabeth, Afzali, Hossein, Arthur, Thomas, Dawson, Amanda, Dudi‐Venkata, Nagendra N.
Publikováno v:
Colorectal Disease; Apr2021, Vol. 23 Issue 4, p989-1000, 12p
Publikováno v:
Oncology Times; 2021 Supplement, Vol. 43, p23-23, 1p
Autor:
Garancher, Alexandra, Suzuki, Hiromichi, Haricharan, Svasti, Masihi, Meher Beigi, Rusert, Jessica M, Norris, Paula S, Carrette, Florent, Romero, Megan M, Morrissy, Sorana A, Skowron, Patryk, Cavalli, Florence M.G., Farooq, Hamza, Ramaswamy, Vijay, Jones, Steven J.M., Moore, Richard A, Mungall, Andrew J, Ma, Yussanne, Thiessen, Nina, Li, Yisu, Morcavallo, Alaide
Publikováno v:
Neuro-Oncology; 2019 Supplement, Vol. 21, pii93-ii93, 1p
Autor:
Prakash M. Nadkarni
While the use of database technology is ubiquitous throughout IT (and health IT in particular), it is not generally appreciated that, as a database increases in scope, certain designs are far superior to others. In biomedical domains, new knowledge i